ABSTRACT N-Methyl-D-aspartate receptors (NMDARs) are major targets of both acute and chronic alcohol, as well as regulators of plasticity in a number of brain regions. Aberrant plasticity may contribute to the treatment resistance and high relapse rates observed in alcoholics. Recent work suggests that chronic alcohol treatment preferentially modulates both the expression and subcellular localization of NMDARs containing the GluN2B subunit. Signaling through synaptic and extrasynaptic GluN2B-NMDARs has already been implicated in the pathophysiology of various other neurological disorders. NMDARs interact with a large number of proteins at the glutamate synapse, and a better understanding of how alcohol modulates this proteome is needed. We employed a discovery-based proteomic approach in subcellular fractions of hippocampal tissue from chronic intermittent alcohol (CIE)-exposed C57Bl/6J mice to gain insight into alcoholinduced changes in GluN2B signaling complexes. Protein enrichment analyses revealed changes in the association of post-synaptic proteins, including scaffolding, glutamate receptor and PDZ-domain binding proteins with GluN2B. In particular, GluN2B interaction with metabotropic glutamate (mGlu) 1/5 receptor-dependent long-term depression (LTD)-associated proteins such as Arc and Homer 1 was increased, while GluA2 was decreased. Accordingly, we found a lack of mGlu 1/5 -induced LTD while α 1 -adrenergic receptor-induced LTD remained intact in hippocampal CA1 following CIE. These data suggest that CIE specifically disrupts mGlu 1/5 -LTD, representing a possible connection between NMDAR and mGlu receptor signaling. These studies not only demonstrate a new way in which alcohol can modulate plasticity in the hippocampus but also emphasize the utility of this discovery-based proteomic approach to generate new hypotheses regarding alcohol-related mechanisms.
INTRODUCTION
Alcoholism is a complex and multi-faceted disease with a high persistence over the life span owing in large part to high rates of relapse. These high relapse rates indicate both that current treatment options are largely ineffective and that alcohol use imparts long-lasting neural changes that persist even after discontinued use. N-Methyl-D-aspartate receptors (NMDARs) are likely candidates for these enduring changes given their necessity in various forms of neural plasticity. Indeed, acute (Dildy & Leslie 1989; Hoffman et al. 1989; Lovinger et al. 1989 ) and chronic Kalluri et al. 1998; Kumari 2001; Nagy et al. 2003; Pawlak et al. 2005; Sheela Rani & Ticku 2006) alcohol exposures are known modulators of NMDARs and disrupt NMDAR plasticity in a number of regions (Blitzer et al. 1990; Givens 1995; Grover & Frye 1996; Schummers & Browning 2001; Hendricson et al. 2002; Izumi et al. 2005; Weitlauf et al. 2004) . Therefore, understanding mechanisms by which alcohol exerts its effects on NMDARs will be critical in developing new therapeutic interventions to intercede in the aberrant plasticity imparted by chronic alcohol use.
N-Methyl-D-aspartate receptors are composed of two obligatory GluN1 subunits and two subunits of either GluN2 or GluN3. The GluN2 subunits are predominately expressed in the adult forebrain, with lower levels of GluN3 subunit expression. Of these GluN2 subunits, GluN2A and GluN2B have the highest expression, and their incorporation into the receptor complex regulates many NMDAR properties (Cull-Candy et al. 2001; Traynelis et al. 2010) . Several studies have explored the potential subunit selective effects of acute alcohol treatments and found mixed results depending on experimental parameters: recombinant receptors, brain region assessed, the phosphorylation state of subunits, and age (reviewed by Wills & Winder 2013) .
In contrast to the acute inhibitory effects of alcohol on NMDARs, withdrawal from chronic alcohol treatments has been frequently reported to enhance their function Kalluri et al. 1998; Kumari 2001; Nagy et al. 2003; Pawlak et al. 2005; Sheela Rani & Ticku 2006) . This enhancement is preferential to the GluN2B subunit, which shows a general increase in expression and function in numerous brain regions after chronic alcohol exposure (Blevins et al. 1995; Follesa & Ticku 1995; Hu et al. 1996; Blevins et al. 1997; Kalluri et al. 1998; Hardy et al. 1999; Narita et al. 2000; Matsumoto et al. 2001; Henniger et al. 2003; Nagy et al. 2003; Hendricson et al. 2007; Qiang et al. 2007; Kash et al. 2009; Wills et al. 2012) ; however, GluN2A increases have also been seen in a few studies Kalluri et al. 1998) . Chronic alcohol use and withdrawal also alter the location of these NMDARs. For example, chronic alcohol use increases synaptic clustering of NMDARs (Carpenter-Hyland et al. 2004; Hendricson et al. 2007; Qiang et al. 2007) , while withdrawal relocates GluN2B-NMDARs to extrasynaptic sites (Clapp et al. 2010; Wills et al. 2012) . The localization of these GluN2B-NMDARs can differentially promote either long-term potentiation (LTP) or long-term depression (LTD) (Liu et al. 2004; Massey et al. 2004; Barria & Malinow 2005; Bartlett et al. 2007; Brigman et al. 2010) presumably as a result of divergent GluN2B signaling at either synaptic or extrasynaptic locations (Newpher & Ehlers 2009) . Numerous recent studies have implicated extrasynaptic GluN2B-NMDAR transmission in the pathologies of a number of neurological disorders (Gladding & Raymond 2011; Hardingham & Bading 2010) . Elucidating the mechanisms responsible for the effects of alcohol on subcellular localization of GluN2B-NMDARs and corresponding changes in their signaling cascades will be critical for developing treatments to rectify aberrant plasticity produced during alcoholism.
The current studies were designed to identify novel alcohol-related changes in GluN2B signaling. While many studies have demonstrated that synaptic and extrasynaptic NMDARs engage distinct signaling pathways, it is unknown what signaling is involved in alcohol-induced relocalization of GluN2B-NMDARs and how this might affect the subsequent function of these receptors. To elucidate these mechanisms, we used a proteomic approach to obtain an unbiased global view of proteins associated with GluN2B-NMDARs and the impact of withdrawal from chronic intermittent ethanol (CIE-W) exposure on these interactions in the hippocampus. CIE-W has been shown to be a good model of dependence as it increases voluntary ethanol consumption and produces increase in anxiety-like behavior (Becker & Lopez 2004; Kash et al. 2009 ). Glutamatergic synapses in the hippocampus are very well characterized and modulated by alcohol. In this study, we targeted proteins specifically associated with GluN2B-NMDARs immunoprecipitated separately from synaptic and non-synaptic subcellular fractions. We were able to identify GluN2B-associated proteins that are sensitive to chronic alcohol exposure in synaptic and non-synaptic locations. The association of post synaptic density (PSD) scaffolding proteins was particularly sensitive to alcohol with a consistently decreased association with GluN2B, suggesting that chronic alcohol dissociates GluN2B-NMDARs from the PSD. A second constellation of proteins that were significantly changed by chronic alcohol have all been linked to metabotropic glutamate (mGlu) 1/5 -LTD. Electrophysiology experiments further confirmed that mGlu 1/5 -LTD was selectively disrupted after chronic alcohol treatment.
MATERIALS AND METHODS

Animals
Male C57BL/6J (6-8 weeks of age; Jackson Laboratories, Bar Harbor, ME, USA) and conditional GluN2B-knockout (KO) (C57BL/6J background; described by Wills et al. 2012) mice housed in groups of two to five in temperature-controlled and humidity-controlled animal facilities are maintained on a 12:12-hour light : dark cycle (lights on 06:00 AM-06:00 PM). Food and water were available ad libitum. All procedures were approved by the Animal Care and Use Committee at Vanderbilt.
Treatment/tissue collection
In these studies, adult male C57Bl/6J mice underwent the CIE-W procedure. Mice were given a daily injection of either pyrazole (air control, 1 mmol/kg) or pyrazole + ethhanol (ethanol group, 1 mmol/kg + 0.8 g/kg, respectively) to impair the metabolism of ethanol. Thirty minutes after the injection, mice were placed in their home cages into a chamber filled with volatilized ethanol (20.3 ± 0.2 mg/l) or volatilized water (air group). Airf low through the chambers was maintained at 5.5 l/min, and volatilization was maintained at 1.5 l/min. After 16 hours of exposure, mice were removed from the chambers and returned to standard animal housing. Ethanol chamber exposure occurred from 04:00 PM to 08:00 AM the following day. Using these parameters, we can reliably obtain blood ethanol concentrations in the range of 150-185 mg/dl. CIE-W was comprised of two 4-day cycles of 16 hours in ethanol vapor chambers and 8 hours out of vapor chambers (Fig. 1a) . Five hours following the final vapor chamber exposure, 0.35-mm tissue punches were collected from 500-μm slices within the hippocampus (eight mice per sample; Fig. 1b) containing portions of CA1, CA3 and the dentate gyrus. Tissue punches were also obtained from the hippocampus of conditional GluN2B-KO mice (Wills et al. 2012 ) with an~80 percent reduction in levels of GluN2B (Badanich et al. 2011) . GluN2B-KO mice were not exposed to vapor chambers. For western blot analysis, a separate cohort of mice was exposed to ethanol or air as described earlier. Five hours following the final vapor chamber exposure, whole hippocampi were dissected for subcellular fractionation, GluN2B immunoprecipitation (IP) and then western blot analysis.
Subcellular fractionation and GluN2B immunoprecipitations
Synaptic (Triton and deoxycholate-soluble) and nonsynaptic (Triton-soluble) fractions were generated from all of these tissue samples (Gustin et al. 2011; Baucum et al. 2013) (Fig. 1c) . Tissue was homogenized in a 
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GluN2B proteome in CIE micehomogenization buffer (150 mM KCl, 50 mM Tris-HCl pH 7.5, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl f luoride, 1 mM benzamidine, 1 μM pepstatin-, 10 μg/ml leupeptin and 1 μM microcystin-LR) using Kontes glass tissue grinders (Kimble-chase, Vineland, NJ) at 4°C. Total homogenate was rocked for 30 minutes at 4°C and centrifuged at 100 000 × g for 1 hour, yielding an S1 fraction (soluble cytosolic protein pool) and a P1 pellet (insoluble fraction). The cytosolic fractions (S1) were not used in further analysis. P1 was resuspended in a homogenization buffer containing 1 percent (v/v) Triton X-100 using a Kontes rounded-tip cone pestle and rocked for 30 minutes at 4°C. The homogenate was then centrifuged at 16 000 × g for 10 minutes at 4°C, yielding an S2 fraction (membrane-associated protein pool) and a P2 pellet (Triton-insoluble fraction). The P2 was sonicated at 4°C in a homogenization buffer containing 1 percent (v/v) Triton X-100 and 1 percent (w/v) sodium deoxycholate and rocked for 30 minutes at 4°C. Pre-cleared samples (300 μl) were incubated at 4°C for 1 hour with mouse antisera to GluN2B (7.5 μl; antibody from BD Transduction Laboratories BD Biosciences San Jose, CA), protein G magnetic beads (Pierce Biotechnology Rockford, IL) were added and samples were incubated overnight at 4°C. Immunoprecipitates were washed three times with 1 ml of IP buffer and suspended in 2× sodium dodecyl sulfate (SDS) sample buffer and separated by SDS-polyacrylamide gel electrophoresis (PAGE) (Baucum et al. 2010 (Baucum et al. , 2013 (Fig. 1d) .
Mass spectrometry
Sample lanes were subdivided into three separate samples (black brackets on blots; Fig. 1 ) to maximize protein coverage in the mass spectrometer (MS). Co-IPs from the synaptic and non-synaptic fractions in air, CIE-W and KO mice were then analyzed via liquid chromatography (LC)-MS/MS (Proteomics Core of Mass Spectrometry Research Center; LTQ-Orbitrap; Fig. 1E ). MS/MS spectra of the peptides were obtained using data-dependent scanning, in which one full MS spectrum was followed by 16 MS/MS spectra, drawn from the most intense ions observed in each MS spectrum. Peptiome 1.1.50 (Dasari et al. 2012) identified peptides corresponding to the MS/MS scans by comparing them with spectra from the National Institute of Standards and Technology mouse ion trap library (or an equal number of shuff led decoy spectra; Lam et al. 2010) . IDPicker 3 filtered away peptide-spectrum matches with a greater than 2 percent q-value, and then proteins were assembled with the requirement that each protein group was required to have at least two distinct peptides in evidence, with parsimony applied ). Pepitome and IDPicker are available with source code from http://proteowizard.sourceforge.net/. A protein false discovery rate of 4.93 percent resulted from the set of 55 LC-MS/MS experiments. Data were placed into a hierarchy that separated early and late experiments, with synaptic and non-synaptic samples separated within the folders, with each of these folders separated into 'KO', 'EtOH' and 'air' categories (only early experiments included 'KO').
Proteomic statistics
The average spectral counts of synaptic air and CIE-W samples were compared with those of KO samples. Only proteins with higher average spectral counts in the experimental samples compared with KO samples were included in further analysis. This KO edit was included to remove non-specific protein interactions; however, an 'all or nothing' approach was not employed because of the incomplete GluN2B deletion in these mice (Badanich et al. 2011) . This same KO filtering process was applied to non-synaptic groups. Fisher's exact test was used to test if the spectral counts were different between experiment and control groups. A two-by-two contingency table is constructed for each protein. The four components in the table were (1) spectral counts for this protein in the experimental group; (2) spectral counts for this protein in the control group; (3) spectral counts for all other proteins in the experimental group; and (4) spectral counts for all other proteins in the control group. The P-values from duplicated MS runs in synaptic or non-synaptic fractions were combined by Fisher's P-value combination method. All the P-values were adjusted by a Benjamini-Hochberg multiple comparison adjustment.
Immunoblot analysis
The proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes. Nitrocellulose membranes were blocked in 5 percent milk in Tris-buffered saline with Tween 20 and incubated with the appropriate primary and secondary antibodies. For detection using the Odyssey system (LI-COR Biosciences, Lincoln, NE, USA), infrared-conjugated secondary antibodies (LI-COR) were used. Densitometry was performed using Image J (National Institutes of Health, Bethesda, MD, USA) on images linearly adjusted for brightness and contrast. Inputs were normalized to Ponceau S staining, while samples from GluN2B-IPs were unnormalized because there were no treatment differences in GluN2B. The following primary antibodies were used: Homer 1 (Synaptic Systems Göttingen, Germany; 1:2000), PSD-95 (Affinity BioReagents Golden, CO; 1:20 000), GluA2 (EMD Millipore Billerica, MA anti-GluR2; 1:2000), Shank 3 (UC Davis/NIH NeuroMab Davis, CA), Arc (Santa Cruz Dallas, TX; 1:500) and mGluR5 (EMD Millipore Billerica, MA; 1:3000).
Slice physiology
Five hours following the final vapor chamber exposure, brains were quickly removed and placed in icecold sucrose artificial cerebrospinal f luid (ACSF): (in mM) 194 sucrose, 20 NaCl, 4.4 KCl, 2 CaCl 2 , 1 MgCl 2 , 1.2 NaH 2 PO 4 , 10.0 glucose and 26.0 NaHCO 3 saturated with 95 percent O 2 /5 percent CO 2 . Slices of 300 μm in thickness were prepared using a Tissue Slicer (Leica Biosystems Inc., Buffalo Grove, IL). Slices were then transferred to a submerged recording chamber where they were perfused with heated (28°C), oxygenated (95 percent O 2 -5 percent CO 2 ) 'normal' ACSF (in mM: 124 NaCl, 4.4 KCl, 2 CaCl 2 , 1.2 MgSO 4 , 1 NaH 2 PO 4 , 10.0 glucose and 26.0 NaHCO 3 , pH 7.2-7.4; 290-310 mOsm) at a rate of about 2 ml/minute. After dissection, slices were transferred to an interface recording chamber where they were perfused with heated (~29°C) and oxygenated (95 percent O 2 -5 percent CO 2 ) ACSF at a rate of~2 ml/minute. Slices were allowed to equilibrate in ACSF for at least 1.5 hours before experiments began. A bipolar stainless steel stimulating electrode and a borosilicate glass recording electrode filled with ACSF were placed in the CA1 region of the hippocampus to elicit and record an extracellular field response in the CA3 region. Baseline responses of excitatory field potentials were recorded for 20 minutes (at 0.05 Hz) followed by the application of dihydroxyphenylglycine (DHPG) (10 minutes; 100 μM) and 50-minute washout. In other experiments, 10 minutes of stable fieldexcitatory post-synaptic potentials ( fEPSPs) was recorded prior to methoxamine application (10 minutes; 40 μM) and 30-minute washout.
RESULTS
Discovery-based proteomic screen
Our discovery-based proteomic approach was designed to explore the effect of CIE-W (Fig. 1a) on GluN2B-NMDARassociated proteins in C57Bl/6J male mouse hippocampus. Regional specificity was obtained by collecting 0.35-mm tissue punches from the hippocampus (Fig. 1b ) in mice exposed to CIE-W and air controls (eight mice per treatment per sample). Because the literature supports NMDAR synaptic localization changes following chronic alcohol exposure, extracts of the punched tissue were fractionated to separately enrich synaptic and nonsynaptic GluN2B-associated proteins (Gustin et al. 2011; Baucum et al. 2013) (Fig. 1c) . Fractionated samples were immunoprecipitated using an antibody against GluN2B (Baucum et al., , 2013 Brown et al. 2008) to isolate GluN2B-associated proteins. The specificity of the IPs was established by analyzing samples prepared in parallel from conditional GluN2B-KO mice that express ≤20 percent of wild-type GluN2B protein levels in hippocampal tissue (Badanich et al. 2011) . Similar strategies have proven effective in other proteomic analyses (Baucum et al. 2010) . Immune complexes were separated by SDS-PAGE, and the gels were stained with Coomassie blue. Figure 1d shows a representative gel comparing GluN2B immune complexes from synapticenriched (S3) and non-synaptic (S2) fractions from CIE-W, air controls and conditional GluN2B-KO mice. Numerous proteins were detected in representative samples from air and CIE-W-exposed mice, which were much less abundant in samples from GluN2B-KO mice. Moreover, these relatively abundant GluN2B-associated proteins appeared to be distinct in the S3 and S2 fractions, with generally more proteins in the S3 fraction compared with the S2 fraction, as would be expected. MS (LTQ-Orbitrap; Fig. 1e ) was performed on all samples ( four samples per treatment). Proteins detected in high abundance in KO tissue were removed from subsequent analyses (Materials and Methods section). From the MS, there were 829 unique proteins identified in all fractions/all samples/all treatments, of which 105 were removed because of above-threshold detection in GluN2B-KO samples, leaving a total of 724 proteins. Significant treatment effects were determined with Fisher's exact test on protein spectral counts. Of the proteins exhibiting significant treatment effects, 64 proteins were detected in the S3 fraction (Table 1) , and 22 proteins were detected in the S2 fraction (Table 2) .
Pathway analysis of alcohol-induced protein changes
To gain an understanding of the signaling pathways that are significantly changed following CIE-W, we used several pathway enrichment programs, focusing on proteins in the S3 fraction over the S2 fraction because the larger sample size (64 versus 22 proteins) was better suited to detect affected pathways. The list of proteins that were significantly changed (either increased or decreased) in the S3 fraction by CIE-W was compared with the entire mouse genome. The enriched gene ontology (GO) analysis divided many of the synaptically (S3) located proteins that were significantly altered by CIE-W into several broad categories (Fig. 2a) . These categories are binding proteins (51 genes; P = 5.43eÀ08), structural activity proteins (15 genes; P = 1.25eÀ11) and catalytic activity (nucleoside triphosphatase; 14 genes; P = 2.04eÀ08). In the binding protein category, these could be further subdivided into anion binding GluN2B proteome in CIE mice (23 genes; P = 8.76eÀ08), scaffold protein binding (5 genes; P = 9.75eÀ08), PDZ-domain binding (5 genes; P = 9.75eÀ08), and glutamate receptors (7 genes; P = 3.05eÀ10). The second enrichment strategy used was the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, which assesses the enhancement of the significantly changed S3 proteins against genes in known signaling cascades. The KEGG pathway analysis found nine signaling pathways (Fig. 2b ) that were significantly changed by CIE-W treatment: amyotrophic lateral sclerosis (seven genes; P = 1.03eÀ11), systemic lupus erythematosus (six genes; P = 1.91eÀ07), LTP ( five genes; P = 1.91eÀ07), phagosome (six genes; P = 3.42eÀ07), gap junction ( five genes; P = 3.42eÀ07), Huntington's disease (six genes; P = 5.00eÀ07), endocytosis (six genes; P = 8.23eÀ07), proximal tubule bicarbonate reclamation (three genes; P = 6.21eÀ06), ribosome ( four genes; P = 3.69eÀ05) and carbohydrate digestion and absorption (three genes; P = 3.92eÀ05).
Immunoblot validation of selected alcohol-induced protein changes
To confirm the effects of CIE-W on GluN2B-associated proteins from the preceding proteomic screen, immunoblot analyses were also performed. A separate cohort of mice was exposed to CIE-W, and hippocampal tissue was collected. Subcellular fractionations and GluN2B IPs were performed on this tissue in the same manner as in proteomic screens. Immunoblots for GluN2B, Homer 1, PSD-95 and GluA2 were performed on both synaptic (S3) fraction and nonsynaptic (S2) fraction. There was no change in levels of GluN2B in either S3 [t(9) = 1.158; P = 0.28, not significant (NS); data not shown] or S2 [t(10) = 0.213; P = 0.84, NS; data not shown] fractions (inputs) or in the GluN2B-IPs from S3 [t(9) = 1.247; P = 0.24, NS; Fig. 3a ] or S2 [t(10) = 1.079; P = 0.31, NS; Fig. 3b ]. Homer 1 was increased from CIE-Wtreated mice compared with air controls in GluN2B-IPs from S3 fractions [t(9) = 2.293; P < 0.05; Fig. 3c ] with no change in GluN2B-IPs from S2 fractions [t(10) = 0.427; P = 0.68, NS; Fig. 3d ]. For PSD-95, there was a significant decrease in the GluN2B-IP S3 fraction in CIE-W compared with air controls [t(10) = 2.422; P < 0.05; Fig. 3e] , with a corresponding increase in PSD-95 levels in GluN2B-IP S2 fraction for CIE-W compared with air controls [t(10) = 2.697; P < 0.05; Fig. 3f ]. Finally, for GluA2, there was a significant decrease in CIE-W-treated mice compared with air-treated controls in the GluN2B-IP S3 fraction [t(10) = 2.842; P < 0.05; Fig. 3g ]. In conjunction, there was an increase in GluA2 in the GluN2B S2 fraction in CIE-W-treated mice compared with air-treated controls [t(10) = 2.461; P < 0.05; Fig. 3h ]. These findings confirm the selected alcohol-related protein changes found in the proteomic The mouse IDPicker 3 database was used to determine accession numbers for identified proteins. The number is the first number given by the IDPicker. The second column denotes the corresponding protein name that corresponds with the accession number. The spectral columns give the total spectral counts from air and chronic intermittent ethanol (CIE)-treated mice. These are followed by P-values and false discovery rate (FDR) for the product of the individual P-values and FDR by treatment for each cohort. The final column represents the direction of the treatment change from the air-treated group to the CIE-treated group. a There were multiple accession numbers from the analysis.
screen and thus validate this approach in its ability to uncover treatment-specific protein changes. Further, these findings ref lect alcohol-induced changes specifically in GluN2B subunit association with these proteins because CIE-W had no effect on the input levels for Homer 1 [S3: t(9) = 1.605; P = 0.14, NS; S2: t(10) = 0.6968; P = 0.50, NS], PSD-95 [S3: t(10) = 1.095; P = 0.30, NS; S2: t(10) = 0.0046; P = 0.99, NS] and GluA2 [S3: t(8) = 1.306; P = 0.28, NS; S2: t(10) = 0.2242; P = 0.83, NS; data not shown]. In contrast, we were unable to corroborate the proteomic data for Shank 3 and Arc GluN2B-IP changes identified in the S3 fraction with immunoblotbased analyses [Shank 3: t(10) = 0.731, P = 0.48, NS; Arc: t(10) = 0.681, P = 0.51, NS; data not shown]. There was also no treatment change in either protein from the S2 fraction [Shank 3: t(10) = 0.3197, P = 0.76, NS; Arc: t(10) = 0.6026, P = 0.56, NS; data not shown].
Proteomic screen predicts alcohol-induced disruption of group 1 metabotropic glutamate long-term depression
Several of the CIE-induced changes in GluN2B-associated proteins from the synaptic-enriched fraction are indicative of upregulated LTD-associated signaling (Table 1; Potschka et al. 2002; Tappe & Kuner 2006; Cavarsan et al. 2012; Wolf & Tseng 2012; Jakkamsetti et al. 2013; Loweth et al. 2013) . Specifically, we find increased Arc and MEK 1, which can promote group 1 mGlu-LTD, as well as increased Homer 1 (an mGlu scaffold protein). Further, there is a decrease in the GluA2 subunit, the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR), which could be ref lective of LTD. A single report has indicated that acute, highconcentration ethanol can block LTD in the immature hippocampus induced by the broad-spectrum agonist The mouse IDPicker 3 database was used to determine accession numbers for identified proteins. The number is the first number given by the IDPicker. The second column denotes the corresponding protein name that corresponds with the accession number. The spectral columns give the total spectral counts from air-treated and chronic intermittent ethanol (CIE)-treated mice. These are followed by P-values and false discovery rate (FDR) for the product of the individual P-values and FDR by treatment for each cohort. The final column represents the direction of the treatment change from the airtreated group to the CIE-treated group. a There were multiple accession numbers from the analysis.
1-amino-1,3-dicarboxycyclopentane (Overstreet et al. 1997) , but no studies have evaluated the effects of chronic ethanol exposure in the mature hippocampus. To do this, we measured excitatory field potentials ( fEPSPs) evoked by Schaffer collateral stimulation in area CA1 (Sch-CA1) of the hippocampus in slices from either CIE-W or air controls during exposure to the group 1 mGlu agonist DHPG (10 minutes). DHPG produced a rapid and long-lasting depression of fEPSPs in slices from air controls but failed to have a significant effect on fEPSPs in slices from CIE-W mice [t(7.661) = 2.753; P < 0.05; Fig. 4a and b] . We next performed immunoblot analyses for mGlu5 in the hippocampus and found no significant changes in levels of mGlu5 protein in S1 [cytoplasmic; t (10 We next wanted to determine if this disruption in LTD was specific to group 1 mGlu-LTD or if other forms of LTD were also altered by alcohol. Because NMDAR-dependent low-frequency stimulation LTD can only be induced in the immature hippocampus (Kemp et al. 2000) , it was not feasible to evaluate the effects of CIE-W on this form of plasticity. Therefore, we focused on another form of Gq G proteincoupled receptor (GPCR)-linked LTD induced by activation of α 1 -adrenergic receptors using an α 1 -adrenergic receptor agonist, methoxamine (Scheiderer et al. 2004 ). In the hippocampus, it has been demonstrated that other Gq-coupled GPCR-induced LTDs share common mechanisms (Scheiderer et al. 2004 (Scheiderer et al. , 2008 . To do this, we measured fEPSPs in the Sch-CA1 region of the hippocampus in slices from either CIE-W or air controls during exposure to methoxamine (Table 1 ) compared with the whole mouse genome. Proteins in red font were increased by chronic intermittent ethanol (CIE) and those in green font were decreased by CIE. Note: Both diagrams were modified from their original version to highlight the main treatment effects. [Colour figure can be viewed at wileyonlinelibrary.com] (10 minutes; 40 μM). Methoxamine produced a long-lasting depression of fEPSPs in slices from both CIE-W-treated and air-treated mice [t(14) = 0.7759; P = 0.45, NS; Fig. 4c and d] .
DISCUSSION
We used a discovery-based proteomic approach to assess the impact of chronic alcohol treatment (CIE-W) on GluN2B-associated proteins in synaptic and non-synaptic fractions, identifying a unique subset of CIE-W-regulated interactions in different subcellular compartments. This type of proteomic approach has been previously utilized with the AMPAR and NMDAR to identify both known and novel signaling complexes (Husi et al. 2000; Kang et al. 2012) . While our methods were focused on enriching the GluN2B-NMDAR proteome, it was
Figure 3 Immunoblot analysis of alcohol-induced changes in S3 and S2 fractions. Bar graphs and picture insets show immunoblot data for (a, b) GluN2B, (c, d) Homer1, (e, f) PSD-95 and (g, h) GluA2 from S3 and S2 fractions of GluN2B-immunoprecipitated hippocampal tissue. Immunoblot images for each protein are from the same blot with black boxes used to separate treatment and fraction and numbers are used to delineate molecular weight marker. Bar graphs represent optical density of bands from immunoblots; n = 5-6; *P < 0.05. EtOH = ethanol encouraging that the proteins that were identified overlapped nicely with the previously identified NMDAR proteome (Husi et al. 2000) . An indication into how these proteins might be mechanistically related can be seen in the protein enrichment strategies that we employed. For example, GO enrichment analysis found that many proteins could be classified into PDZ-domain proteins, scaffolding proteins, glutamate receptor binding proteins and structural activity proteins, which are all important in receptor localization and glutamate synapse plasticity. Further, pathway enrichment analysis also implicated several pathways of interest: LTP (a form of plasticity known to be disrupted by alcohol), endocytosis (the mechanism responsible for AMPAR internalization) and Huntington's disease (a disease with a pathophysiology related to extrasynaptic GluN2B-NMDAR transmission; Gladding & Raymond 2011) . The changes in these proteins are capable of providing important clues into the molecular mechanisms responsible for alcoholinduced effects on GluN2B trafficking and how these could relate to altered plasticity. In addition to mechanisms identified by these pathway enrichment strategies, we also surveyed the literature for potentially affected signaling cascades indicated by the protein changes found in these studies. In doing this, we identified several CIE-sensitive proteins linked to mGlu-LTD. Because there was no previous evidence that this form of LTD was modulated by alcohol in the mature hippocampus, we set out to test this mechanism. Our studies here showed that chronic alcohol treatment (CIE-W) was able to profoundly disrupt group 1 mGlu-LTD, but not α 1 -adrenergic receptor-induced LTD.
Disruption of GluN2B and scaffolding proteins at the post-synaptic density
The GO enrichment analysis illustrated that PDZ-domain and scaffold proteins were significantly changed by alcohol exposure. The model in Fig. 5 illustrates many of the scaffolding proteins located at glutamatergic synapses. NMDARs are bound within the synaptic cytoarchitecture by PSD-95. PSD-95 binds to guanylate kinase-associated proteins (GKAPs), which act as a link between NMDAR-PSD and Shank-Homer (Luo et al. 2012) . Dynamic regulation of GKAPs was recently shown to be critical for homeostatic synaptic scaling (Shin et al. 2012) . In these studies, alcohol exposure produces a decrease in GluN2B association with PSD proteins , GKAP (SAPAP 3), and Shank 3 in the synaptic fraction and PSD-93 and Drebrin in the non-synaptic fraction. This decrease in GluN2B association with the PSD scaffolding proteins further supports prior work in hippocampal cultures demonstrating the relocalization of these NMDARs after chronic ethanol (Clapp et al. 2010) . Relocalization is also supported by the decrease in NMDAR subunit (GluN1, GluN2B and GluN2A) association following CIE-W in the synaptic fractions. In other works, genetic KOs of PSD-95 have been shown to alter various alcohol-related behaviors and thus illustrate the importance of the PSD complex in the regulation of alcohol's effects (Camp et al. 2011) .
In hippocampal primary cultures, chronic alcohol produces a synaptic clustering of NMDARs, especially GluN2B-NMDARs (Carpenter-Hyland et al. 2004; Carpenter-Hyland & Chandler 2006) . Other works confirmed this GluN2B synaptic enhancement and illustrated that during alcohol withdrawal GluN2B moved to extrasynaptic locations through lateral diffusion (Clapp et al. 2010) . Further, our previous work in the bed nucleus of the stria terminalis (BNST) also showed that CIE-W seems to enhance transmission at extrasynaptic GluN2B-NMDARs (Wills et al. 2012) . Transmission through these extrasynaptic GluN2B-NMDARs is normally thought to preferentially promote LTD versus LTP (Massey et al. 2004; Newpher & Ehlers 2009) , although evidence in the BNST suggests a potentially enhancing role on transmission (Wills et al. 2012) . Extrasynaptic GluN2B transmission is involved in various excitotoxic processes and implicated in a number of pathological conditions (e.g. Huntington's disease, ischemia, Parkinson's disease and Alzheimer's disease; Gladding & Raymond 2011; Hardingham & Bading 2010) . It is interesting to note that Huntington's disease was identified in our pathway enrichment analysis and its pathology involves extrasynaptic GluN2B. It is possible that common mechanisms may be responsible for the relocation of these receptors in both diseases.
Regulation metabotropic glutamate long-term depression by alcohol
Several of the proteins altered by CIE were found to be involved in mGlu-LTD. Our results found an increased association of synaptic GluN2B with Arc signaling proteins (Arc and MEK 1) and Homer 1 (a mGlu scaffolding protein) along with a decrease in GluA2 (AMPAR subunit). Arc is an immediate early gene that undergoes rapid transcription in response to stimuli and then translocates to the synapse to regulate local translation (Bramham et al. 2008) . Arc is a dynamic regulator of various forms of plasticity in the hippocampus and is critically involved in the endocytosis of AMPARs that occurs during mGlu-LTD. Further, synaptic translation of Arc primes neurons for induction of group 1 mGlu-LTD (Jakkamsetti et al. 2013) . Therefore, in the current work, the increased synaptic association of Arc could be indicative of neurons primed for mGlu-LTD. It is important to note that the change in Arc was not validated with our western blot. Western approaches have weaknesses in their own right, and because the current proteomic screen was so robust in its sample size and statistical analyses, it is potentially more reliable.
Homer proteins are scaffold proteins that serve as the linker between NMDAR-PSD-GKAP-Shank complexes and mGlu 1/5 . Thus, these proteins serve as a convergence point of NMDAR and mGlu signaling. In our studies, we find that Homer 1 association with GluN2B is increased in the synaptic fraction and decreased in the non-synaptic fraction following CIE-W. Homer proteins are known regulators of mGlu 1/5 trafficking and signaling. mGlu 1/5 are highly expressed in the hippocampus, where their activation leads to LTD (Huber et al. 2001; Inta et al. 2012) . Drugs of abuse can induce mGlu-LTD in the accumbens through the internalization of GluA2-containing AMPARs (Wolf & Tseng 2012; Loweth et al. 2013) . mGlu5 signaling is known to play a role in many alcohol-related behaviors (Backstrom et al. 2004; Cowen et al. 2005; Besheer et al. 2006; Hodge et al. 2006; Lominac et al. 2006; Besheer et al. 2008 Besheer et al. , 2010 Adams et al. 2010; Sinclair et al. 2012) . Recent work further demonstrates a role of group I mGlu-Homer signaling on ethanol binge drinking (Cozzoli et al. 2013 ). Ethanol has also been shown to occlude GluN2B-dependent LTD in the nucleus accumbens (Jeanes et al. 2011) indicating a potential connection between GluN2B transmission and LTD mechanisms. Because the current work finds an increased synaptic association of GluN2B and Homer 1, it suggests that CIE-W is disrupting mGlu 1/5 -LTD in the hippocampus.
Indeed, we find no evidence of DHPG-induced depression (LTD) in alcohol-treated mice, which was readily induced in control mice. This result suggests that chronic alcohol disrupts mGlu-LTD induction mechanisms or that LTD is induced in vivo and thus occludes further LTD by DHPG. Our proteomic data argue for the latter because increased Arc and decreased GluA2 are indicative of LTD induction. Further, there is no change in mGluR5 protein levels, which also suggests that the induction mechanism seems to be intact. This disruption of group I mGlu-LTD was not generalizable to other forms of Gq GPCR-linked LTD because α 1 -adrenergic receptorinduced LTD was intact following CIE-W. This α 1 -adrenergic receptor-induced LTD at these hippocampal synapses has previously been shown to be activity and NMDAR dependent and rely on Erk signaling (Scheiderer et al. 2004 (Scheiderer et al. , 2008 . Thus, the retention of this LTD following CIE-W suggests that both NMDAR-dependent induction mechanisms and Erk signaling remain intact. This separable disruption of Gq GPCR-linked LTD has been observed in the BNST, where stress specifically alters α 1 -adrenergic receptor-induced LTD and leaves mGlu 1/5 -LTD intact. The cause for these disparate effects was distinct post-synaptic LTD maintenance mechanisms (McElligott et al. 2010 ).
These studies not only demonstrate a new way in which alcohol can modulate plasticity in the mature hippocampus but emphasize the utility of this discovery-based proteomic approach to generate new hypotheses regarding alcohol-related mechanisms.
CONCLUSIONS
This study illuminates new mechanisms by which chronic alcohol and withdrawal affect plasticity in a region known to be critical to the memory-impairing effects of alcohol, the hippocampus. The hippocampus is a highly studied region, which is highly involved in contextual associations and episodic memory. This context association plays a pivotal role in context-induced relapse to alcohol, and alcohol regulation of memory in this region is responsible for 'blackouts' (see Review of Zorumski et al. 2014) . Additionally, chronic alcohol is known to induce neurotoxicity in hippocampus through activation of NMDARs (particularly GluN2B containing). This neurotoxicity is thought to be involved in certain memory impairments and seizures (Harris et al. 2003; Stepanyan et al. 2008; Lewis et al. 2012) . These behaviors are all critical to the etiology and treatment of alcohol use disorders, and thus, understanding their mechanisms is necessary. Further, these proteomic data have highlighted key proteins that may be responsible for the relocalization of GluN2B-NMDARs to extrasynaptic locations during alcohol withdrawal. This understanding of how signaling mechanisms change as these NMDARs relocate will provide critical information into new therapeutic targets to combat this pathological signaling. Furthermore, information gained from these studies could provide novel insights into numerous neuropsychiatric disorders, which involve disrupted GluN2B signaling (Gladding & Raymond 2011) . 
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